跳至主要内容
临床试验/NL-OMON23273
NL-OMON23273尚未招募不适用

Single-cell analysis of somatic mutations to understand and improve hematopoiesis after transplantation

Princess Máxima Center for Pediatric Oncology0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • (1) Allogeneic HSCT with bone marrow cells from a healthy sibling donor; (2) Age at HSCT <18 yrs; (3) First HSCT; (4) Availability of viably frozen donor bone marrow cells from the Biobank of the UMC Utrecht; (5) >95% donor chimerism; (6) No major HSCT-related complications (see exclusion criteria).

排除标准

  • (1) Major HSCT-related complications, such as >grade 2 graft versus host disease; (2) Secondary graft failure; (3) Objection to be notified about actionable findings from whole-genome sequencing; (4) Failure of the HSCT recipient, donor and/or their legal representatives to understand the patient information and informed consent form (either due to intellectual disability or to language problems). Of note: Only include subjects in whom both the HSCT recipient and his/her donor (and, if applicable, their caregivers) agree to participate in the current study are eligible.

研究者

发起方
Princess Máxima Center for Pediatric Oncology

相似试验